Recent trade makes NovoCure Ltd (NVCR) Stock an appealing buy
JP Morgan raised the price target for the NovoCure Ltd (NASDAQ:NVCR) stock to “a Neutral”. The rating was released on November 20, 2023, according to finviz. We previously noted in another research note published on August 28, 2023 by H.C. Wainwright that downgraded the stock from a Buy to a Neutral with a price target […]
A good growth outlook is seen for Beam Therapeutics Inc (BEAM) Stock by analysts
JP Morgan raised the price target for the Beam Therapeutics Inc (NASDAQ:BEAM) stock from “a Neutral” to “an Overweight”. The rating was released on January 29, 2024, according to finviz. The research report from Jefferies has downgraded the stock from Buy to Hold, with a price target set at $30. The stock was downgraded by […]
Wolfe Research Sets Solid Power Inc (NASDAQ:SLDP) Stock to “an Underperform”
Wolfe Research raised the price target for the Solid Power Inc (NASDAQ:SLDP) stock from “a Peer perform” to “an Underperform”. The rating was released on June 08, 2023, according to finviz. The research report from Citigroup has initiated the stock to Neutral, with a price target set at $3. The stock was initiated by Stifel, […]
NextDecade Corporation (NASDAQ:NEXT) Stock reiterated by TD Cowen
TD Cowen raised the price target for the NextDecade Corporation (NASDAQ:NEXT) stock to “a Buy”. The rating was released on June 06, 2024, according to finviz. The research report from Stifel has upgraded the stock from Hold to Buy, with a price target set at $9. The stock was upgraded by Stifel, who disclosed in […]
Why Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) Stock Increased 4.39 percent in recent Trade?
JP Morgan raised the price target for the Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) stock to “an Overweight”. The rating was released on November 20, 2023, according to finviz. We previously noted in another research note published on September 18, 2023 by RBC Capital Mkts that upgraded the stock from a Sector perform to an Outperform with […]
Is price-to-earnings ratio of 41.13 for Ibotta Inc. (NYSE:IBTA) Stock digestible?
Wells Fargo raised the price target for the Ibotta Inc. (NYSE:IBTA) stock to “an Overweight”. The rating was released on May 13, 2024, according to finviz. The research report from JMP Securities has initiated the stock to Mkt Outperform, with a price target set at $130. The stock was initiated by Goldman, who disclosed in […]
Why AbCellera Biologics Inc (NASDAQ:ABCL) Stock Slipped -24.68% in Last Month?
The Benchmark Company raised the price target for the AbCellera Biologics Inc (NASDAQ:ABCL) stock from “a Hold” to “a Buy”. The rating was released on February 22, 2024, according to finviz. The stock was resumed by Piper Sandler, who disclosed in a research note on October 13, 2023, to Overweight and set the price objective […]
Quantum Computing Inc (NASDAQ:QUBT) Stock Price Slipped -4.17% to $0.57
The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -13.53% within the last five trades and -21.93% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -37.55% in the last 6 months […]
Consensus Analyst Estimated Price Target of $9.20 for Domo Inc. (NASDAQ:DOMO) Stock
Lake Street raised the price target for the Domo Inc. (NASDAQ:DOMO) stock from “a Buy” to “a Hold”. The rating was released on May 24, 2024, according to finviz. The research report from TD Cowen has downgraded the stock from Outperform to Market Perform, with a price target set at $14. The stock was downgraded […]
Why Ameresco Inc. (NYSE:AMRC) Stock went down -31.20% in Last Year?
Exane BNP Paribas raised the price target for the Ameresco Inc. (NYSE:AMRC) stock from “a Neutral” to “an Outperform”. The rating was released on March 12, 2024, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $37. The latest trade, Performances […]
